Most Americans don't see GLP-1 weight loss as cheating
Core finding
Nearly six-in-ten Americans (58%) reject the idea that using a GLP-1 medication for weight management amounts to “cheating,” according to a Verasight survey fielded Dec. 22, 2025 to Jan. 5, 2026.
About one-in-five (20%) do call it cheating, and roughly the same share (22%) are unsure.
Topline distribution
Most Americans don't see GLP-1 weight loss as cheating.
Do you believe using a GLP-1 medication for weight management is “cheating”?
n = 1,000 · Dec 22, 2025 – Jan 5, 2026 · MoE ±3.1%
Methodology
Full methodology →| Mode | Verasight panel recruited via random address-based sampling, random person-to-person text messaging, and dynamic online targeting |
|---|---|
| Population | United States adults |
| Field dates | Dec 22, 2025 – Jan 5, 2026 |
| Base (unweighted) | 1,000 |
| Margin of error | ±3.1% |
| Module | predictions |
| Sponsor | Verasight |
| Weight variable | weight for AI and predictions questions; weight_popculture for pop culture questions |
| Weighting targets | age, race/ethnicity, sex, income, education, region, metropolitan status |
Sources
- reports.verasight.io/r/2026-predictions
Do you believe using a GLP-1 medication for weight management is “cheating”?
Cite this question
2026 Predictions Survey #2025-183, fielded December 22, 2025-January 5, 2026, N=1,000 United States adults, +/- 3.1%.